Methods to characterize enzymes for genome engineering
AssigneeThe General Hospital Corporation
InventorsBenjamin Kleinstiver, Russell T. Walton
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe General Hospital Corporation
InventorsBenjamin Kleinstiver, Russell T. Walton
Estimating the term…
The disclosure provides methods for the concurrent assessment of large numbers of genome engineering proteins, including CRISPR nucleases and base editors. Specifically, the disclosure provides methods of providing a plurality of individual discrete samples comprising populations of cells, wherein each population of cells overexpresses both (i) a single genome engineering protein or a variant thereof and (ii) a reporter protein, lysing the cells to release the proteins; normalizing levels of the genome engineering proteins or variants thereof; allowing the genome engineering proteins or variants thereof to combine with a guide RNA under conditions sufficient to form ribonucleoprotein complexes in each sample; contacting each sample with a plurality of analysis substrates, determining levels of each of the analysis substrate in each sample at a plurality of times; and calculating rate of depletion or enrichment of each of the analysis substrates from each sample.
Providing a plurality of individual discrete samples comprising populations of cells, preferably mammalian cells, preferably human cells, wherein each population of cells overexpresses both (i) a single genome engineering protein or a variant thereof and (ii) a reporter protein, wherein (i) and (ii) are expressed in a known ratio, preferably 1:1, in the samples;
Dependencies are inferred from the claim text.